A new study throws light on the availability
of prescription-based medical abortion drugs with chemists as a way to prevent
early abortion care costs among other benefits for women exercising their
choice of terminating pregnancy
Written by Jayashree Narayanan
Published: August 19, 2020
Marking 49 years of the inception of the Medical Termination of Pregnancy (MTP)
Act in 1971, a new study out on August 10, 2020 evaluated the availability of
Medical Abortion (MA) drugs in six Indian states to understand the awareness
levels and perceptions of the chemists stocking and selling MA pills.
Despite the passage of the MTP (Amendment) Bill in March 2020 that extended the
upper limit for permitting abortion to 24 weeks from 20 weeks, the
non-availability of MA drugs, which are approved for use up to nine weeks of
pregnancy in India, is seen to be “threatening” to women’s access to safe
abortion and proper reproductive healthcare.
Continued: https://indianexpress.com/article/lifestyle/health/medical-abortion-pills-mtp-act-chemist-study-6552205/